Currently, CHPF has been reported to be upregulated in lung adenocarcinoma, non‐small‐cell lung cancer, gliomas and malignant melanoma, etc. [15, 16, 17, 18], suggesting that it plays an important role in tumor progression. Here, CHPF is linked to neoplasm.